HIV Citations List: March 2024
Literature Citations
1. Oxime Derivatives of Betulonic acid and Platanic acid as Novel Cytotoxic or Antiviral Agents. Cerná, L., U. Bildziukevich, L. Rárová, J. Trylcová, D. Saman, J. Weber, P. Lovecká, and Z. Wimmer. Reaction Chemistry & Engineering, 2024. 2024(2). ISI[001167274800001].
[WOS]. HIV_03_2024.
2. Improving anti-HIV Activity and Pharmacokinetics of Enfuvirtide (T20) by Modification with Oligomannose. Cheng, S., M. Xu, M. Li, Y. Feng, L. He, T. Liu, L. Ma, and X. Li. European Journal of Medicinal Chemistry, 2024. 269: 116299. PMID[38479167].
[PubMed]. HIV_03_2024.
3. Glycan-modified Peptides for Dual Inhibition of Human Immunodeficiency Virus Entry into Dendritic Cells and T Cells. Cheng, S.H., M.L. Li, Y. Feng, T. Liu, L. He, M.Y. Xu, L.Y. Ma, and X.B. Li. Journal of Medicinal Chemistry, 2024. 67(5): p. 4225-4233. PMID[38364308].
[PubMed]. HIV_03_2024.
4. Advancing Natural Product Discovery: A Structure-oriented Fractions Screening Platform for Compound Annotation and Isolation. Ge, Y., C. Zhou, Y. Ma, Z. Wang, S. Wang, W. Wang, and B. Wu. Analytical Chemistry, 2024. 96(14): p. 5399-5406. PMID[38523322].
[PubMed]. HIV_03_2024.
5. Inhibition of HIV-1 Release by Adam metalloproteinase Inhibitors. Ireland, J., J. Segura, G. Shi, J. Buchwald, G. Roth, T.J. Shen, R. Wang, X. Ji, E.R. Fischer, S. Moir, T.W. Chun, and P.D. Sun. Frontiers in Microbiology, 2024. 15: 1385775. PMID[38572241]. [PMC10987949].
[PubMed]. HIV_03_2024.
6. Weekly Oral Tenofovir Alafenamide Protects Macaques from Vaginal and Rectal Simian HIV Infection. Massud, I., K. Nishiura, S. Ruone, A. Holder, C. Dinh, J. Lipscomb, J. Mitchell, G.M. Khalil, W. Heneine, J.G. Garcia-Lerma, and C.W. Dobard. Pharmaceutics, 2024. 16(3): 384. PMID[38543278]. [PMC10974356].
[PubMed]. HIV_03_2024.
7. Identification of Clickable HIV-1 Capsid-targeting Probes for Viral Replication Inhibition. McFadden, W.M., M.C. Casey-Moore, G.A.L. Bare, K.A. Kirby, X. Wen, G. Li, H. Wang, R.L. Slack, A.A. Snyder, Z.C. Lorson, I.L. Kaufman, M.E. Cilento, P.R. Tedbury, M. Gembicky, A.J. Olson, B.E. Torbett, K.B. Sharpless, and S.G. Sarafianos. Cell Chemical Biology, 2024. 31(3): p. 477-486.e477. PMID[38518746].
[PubMed]. HIV_03_2024.
8. Design and Synthesis of Fsp(3)-enriched Spirocyclic-substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs. Sang, Z., T. Zhang, Z. Wang, E. De Clercq, C. Pannecouque, D. Kang, P. Zhan, and X. Liu. Chemical Biology & Drug Design, 2024. 103(3): e14510. PMID[38519265].
[PubMed]. HIV_03_2024.
9. Structure-based Design and Optimization Lead to the Identification of Novel Dihydrothiopyrano[3,2-d]pyrimidine Derivatives as Potent HIV-1 Inhibitors against Drug-resistant Variants. Wang, Z., H. Zhang, Z. Gao, Z. Sang, E. De Clercq, C. Pannecouque, D. Kang, P. Zhan, and X. Liu. Acta Pharmaceutica Sinica B, 2024. 14(3): p. 1257-1282. PMID[38486991]. [PMC10935503].
[PubMed]. HIV_03_2024.
10. Total Syntheses of Phorbol and 11 Tigliane diterpenoids and Their Evaluation as HIV Latency-reversing Agents. Watanabe, A., M. Nagatomo, A. Hirose, Y. Hikone, N. Kishimoto, S. Miura, T. Yasutake, T. Abe, S. Misumi, and M. Inoue. Journal of the American Chemical Society, 2024. 146(12): p. 8746-8756. PMID[38486375].
[PubMed]. HIV_03_2024.
11. Structure-based Design of Diarylpyrimidines and Triarylpyrimidines as Potent HIV-1 NNRTIs with Improved Metabolic Stability and Drug Resistance Profiles. Xie, M., Z. Wang, F. Zhao, Y. Li, Z. Zhuo, X. Li, E. De Clercq, C. Pannecouque, P. Zhan, X. Liu, and D. Kang. Journal of Medical Virology, 2024. 96(3): e29502. PMID[38450817].
[PubMed]. HIV_03_2024.
12. Design, Synthesis and Biological Evaluation of Indole-2-carboxylic acid Derivatives as Novel HIV-1 Integrase Strand Transfer Inhibitors. Zhang, R.H., G.Q. Chen, W. Wang, Y.C. Wang, W.L. Zhang, T. Chen, Q.Q. Xiong, Y.L. Zhao, S.G. Liao, Y.J. Li, G.Y. Yan, and M. Zhou. RSC Advances, 2024. 14(13): p. 9020-9031. PMID[38500630]. [PMC10945512].
[PubMed]. HIV_03_2024.
Patent Citations
This month, no relevant HIV patents were identified.